Gait and balance training for Parkinson's (NCT06617884)
Enhance home walking and balance
- Trial ID
- NCT06617884
- Official Title
- Comparison of Two Home-based Gait and Balance Trainings With Different Training Frequencies in Patients With Parkinson's Disease and Ataxia
- Goal
- Enhance home walking and balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Forschungszentrum Juelich
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Ataxia, Parkinson Disease
- Interventions
- Gait and balance training
Summary For Families
Researchers are testing whether different schedules of home-based gait and balance exercises can improve walking, stability, and daily mobility in people with Parkinson's disease or cerebellar ataxia, and whether one frequency is more effective at reducing fall risk. Participants follow guided at-home training that targets stepping, coordination, timing, and leg strength to retrain balance responses and gait patterns through repetition and motor learning, this is a non-drug approach meant to complement medications like levodopa rather than replace them. Adults 18 to 75 with a clinical diagnosis of idiopathic Parkinson's syndrome or cerebellar ataxia who can walk at least four meters at home are eligible, while those with frequent falls (one or more per week), other major motor-impacting illnesses, severe psychiatric disease, addiction, poor general health, or inability to consent are excluded; Parkinson's participants must be able to be measured during their on-medication phase.
Locations
- Universitätsklinikum Düsseldorf, Institut für Klinische Neurowissenschaften und Medizinische Psychologie, Düsseldorf, North Rhine-Westphalia, Germany
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Gait and balance training. Researchers are testing whether different schedules of home-based gait and balance exercises can improve walking, stability, and daily mobility in people with Parkinson's disease or cerebellar ataxia, and whether one frequency is more effective at reducing fall risk. Participants follow guided at-home training that targets stepping, coordination, timing, and leg strength to retrain balance responses and gait patterns through repetition and motor learning, this is a non-drug approach meant to complement medications like levodopa rather than replace them. Adults 18 to 75 with a clinical diagnosis of idiopathic Parkinson's syndrome or cerebellar ataxia who can walk at least four meters at home are eligible, while those with frequent falls (one or more per week), other major motor-impacting illnesses, severe psychiatric disease, addiction, poor general health, or inability to consent are excluded; Parkinson's participants must be able to be measured during their on-medication phase.
- Who can participate?
- Participants must be between 18 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment groups. Because assignment is random, you have about a 1 in 3 chance (roughly 33%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- You will come to three in-person study visits and take part in a three-week training phase.